These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1712233)

  • 21. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
    Iwata K; Seya T; Ariga H; Nagasawa S
    J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical c3 convertase, C4b,2a.
    Nicholson-Weller A; Burge J; Austen KF
    J Immunol; 1981 Nov; 127(5):2035-9. PubMed ID: 6913607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solution structure of a functionally active fragment of decay-accelerating factor.
    Uhrinova S; Lin F; Ball G; Bromek K; Uhrin D; Medof ME; Barlow PN
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4718-23. PubMed ID: 12672958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor.
    Medof ME; Kinoshita T; Silber R; Nussenzweig V
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2980-4. PubMed ID: 2581259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor.
    Brodbeck WG; Liu D; Sperry J; Mold C; Medof ME
    J Immunol; 1996 Apr; 156(7):2528-33. PubMed ID: 8786315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor.
    Holguin MH; Martin CB; Bernshaw NJ; Parker CJ
    J Immunol; 1992 Jan; 148(2):498-502. PubMed ID: 1370313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59.
    Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4195-202. PubMed ID: 11095615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of glycoinositolphospholipid anchor lipid groups on functional properties of decay-accelerating factor protein in cells.
    Walter EI; Ratnoff WD; Long KE; Kazura JW; Medof ME
    J Biol Chem; 1992 Jan; 267(2):1245-52. PubMed ID: 1370460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5430-4. PubMed ID: 6225118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of decay-accelerating factor (DAF) in human skin.
    Sayama K; Shiraishi S; Shirakata Y; Kobayashi Y; Miki Y
    J Invest Dermatol; 1991 Jan; 96(1):61-4. PubMed ID: 1702821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor.
    Norris KA; Bradt B; Cooper NR; So M
    J Immunol; 1991 Oct; 147(7):2240-7. PubMed ID: 1717552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55).
    Harris CL; Abbott RJ; Smith RA; Morgan BP; Lea SM
    J Biol Chem; 2005 Jan; 280(4):2569-78. PubMed ID: 15536079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surface membrane expression by human blood leukocytes and platelets of decay-accelerating factor, a regulatory protein of the complement system.
    Nicholson-Weller A; March JP; Rosen CE; Spicer DB; Austen KF
    Blood; 1985 May; 65(5):1237-44. PubMed ID: 2581636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular modeling and mechanism of action of human decay-accelerating factor.
    Kuttner-Kondo L; Medof ME; Brodbeck W; Shoham M
    Protein Eng; 1996 Dec; 9(12):1143-9. PubMed ID: 9010927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
    Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM
    Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of the alternative pathway of complement by glomerular chondroitin sulphate proteoglycan.
    Quigg RJ
    Immunology; 1992 Jul; 76(3):373-7. PubMed ID: 1382039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrovirus-mediated over-expression of decay-accelerating factor rescues Crry-deficient erythrocytes from acute alternative pathway complement attack.
    Kim DD; Miwa T; Song WC
    J Immunol; 2006 Oct; 177(8):5558-66. PubMed ID: 17015743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decay-accelerating factor regulates complement-mediated damage in the human atherosclerotic wall.
    Niculescu F; Rus HG; Vlaicu R
    Immunol Lett; 1990 Oct; 26(1):17-23. PubMed ID: 1703512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats.
    Pérez de la Lastra JM; Harris CL; Hinchliffe SJ; Holt DS; Rushmere NK; Morgan BP
    J Immunol; 2000 Sep; 165(5):2563-73. PubMed ID: 10946283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.
    Nicholson-Weller A; March JP; Rosenfeld SI; Austen KF
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5066-70. PubMed ID: 6576376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.